WOMEN HEALTH CARE PROFESSIONALS MENU Updates Explore Medicines360’s latest news and resources ALL UPDATES BLOG PRESS RELEASES PUBLICATIONS NEWS PRESS RELEASES 2 AUG 2021 Medicines360, MSI Reproductive Choices and MSK Announce Launch of Avibela® Hormonal Intrauterine Device in Kenya Product Expands Access to High-Quality Contraception for Women in Africa SAN FRANCISCO and LONDON and NAIROBI– August 2, 2021 – Medicines360, MSI Reproductive Choices (MSI) and Marie Stopes Kenya (MSK) today announced the launch of AVIBELA (levonorgestrel-releasing intrauterine system) 52 mg in Kenya. This is the third launch of Medicines360’s hormonal intrauterine device (IUD) in […] Read More > PRESS RELEASES 6 JUL 2021 Medicines360 Appoints Tina Raine-Bennett, MD, MPH, FACOG, as Chief Executive Officer Dr. Raine-Bennett brings passionate expertise in improving health outcomes for women SAN FRANCISCO – July 6, 2021 – Medicines360, a global nonprofit women’s health pharmaceutical organization, has appointed Tina Raine-Bennett, MD, MPH, FACOG, Chief Executive Officer (CEO), effective immediately, following a broad national search. With over 30 years of experience, Dr. Raine-Bennett has an extensive […] Read More > PRESS RELEASES 25 JUN 2021 Medicines360 Applauds Introduction of Federal Legislation to Support Nonprofit Pharmaceutical Organizations For Immediate Release: June 25, 2021 SAN FRANCISCO – Today, Senator Jacky Rosen (D-NV) introduced the Expanding Access to Affordable Prescription Drugs and Medical Devices Act, a bill designed to support nonprofit pharmaceutical organizations in their efforts to sustainably increase access to affordable medicines for Americans. As the longest-standing nonprofit pharmaceutical organization serving the U.S. market, […] Read More > PRESS RELEASES 8 JUN 2021 Medicines360 and HRA Partner to Enhance Availability of Emergency Contraceptive ella® in the U.S. SAN FRANCISCO and MORRISTOWN, N.J.: Medicines360, a mission-driven nonprofit women’s health pharmaceutical organization, and HRA Pharma, a global consumer healthcare company, announced today that the two organizations are partnering to support U.S. publicly funded family planning clinics’ access to prescription emergency contraceptive ulipristal acetate (UPA), commonly known in the U.S. as ella®. HRA Pharma first […] Read More > PRESS RELEASES 18 NOV 2020 New Survey Reveals Increasing Barriers for Women Seeking Birth Control and Disproportionate Impact on Women of Color Faced with job losses and disruption from the pandemic, women find it more challenging in 2020 to access birth control, a critical aspect of women’s health San Francisco – November 18, 2020 – Medicines360, a global nonprofit women’s health pharmaceutical organization fighting to make access to medicines for all women a reality, today released the […] Read More > PRESS RELEASES 17 JUL 2020 Medicines360 Appoints Rolf Jansen as Vice President of Drug Development and Manufacturing Jansen to Lead Product Expansion Focused on Essential Medicines Facing Access Challenges SAN FRANCISCO – July 17, 2020 – Medicines360, a global nonprofit women’s health pharmaceutical organization, has appointed Rolf Jansen as the Vice President of Drug Development and Manufacturing. Mr. Jansen is a chemical engineer with more than thirty years of pharmaceutical experience developing […] Read More > 1 2 … 6 NEXT FEATURED UPDATES NEWS 11 MAR 2019 International Women’s Day at Direct Relief International SANTA BARBARA INDEPENDENT – Direct Relief’s Kirchmaier Volunteer Center was standing room only Friday morning, March 8, as more than 150 people gathered in honor of International Women’s Day to celebrate achievements and acknowledge remaining hurdles, including the lack of global access to affordable maternal health care. This year’s theme was “balance for better — […] Read More > PRESS RELEASES 6 SEP 2018 Medicines360, Afaxys Partner to Expand Public Health Access to LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg Strategic alliance will increase engagement with U.S. public health clinics and their patients about hormonal IUDs (long-acting reversible contraceptives, or LARCs) SAN FRANCISCO and CHARLESTON, S.C. – Medicines360 and Afaxys Pharma, LLC, two mission-driven, socially conscious women’s health pharmaceutical companies, today announced their collaboration to promote Medicines360’s intrauterine system (IUS), LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg, which is […] Read More > NEWS 30 MAY 2018 Medicines360 Expands Access To Contraception In Africa FORBES – Medicines360, the non-profit pharmaceutical company behind the hormonal IUD Liletta, is on a mission to increase women’s access to reproductive care around the world. This month, the female-led company announced the launch of Avibela, a hormonal IUD, in Madagascar. Read More > Sign up for news and updates Women Health Care Professionals Our Mission Resources Donate Avibela Project Who We Are Contact Us Jobs Our Team Leadership Board of Directors Founder Products & Pipeline Clinic Locator Updates Blog Press Releases Publications News © 2021 Medicines360. A 501(c)(3) tax-exempt organization. Medicines360® and its design are registered trademarks of Medicines360. All other trademarks are property of their respective owners. Privacy Policy Terms of Use Compliance Community Guidelines Contact Us